R.P. Meijer
Papers
2
Total Citations
155
H-Index
2
About
R.P. Meijer is a leading surgical oncologist whose research centers on intraoperative fluorescence imaging to improve outcomes in colorectal and liver cancer surgery. His most impactful work demonstrates how indocyanine green (ICG) near-infrared fluorescence can solve two critical surgical problems: preventing anastomotic leakage and achieving clear tumor margins. In the landmark AVOID trial (2024, 84 citations), a multicentre randomized controlled phase 3 study, Meijer showed that ICG bowel perfusion assessment significantly reduces anastomotic leakage rates in minimally invasive colorectal surgery—a finding that directly changes clinical practice. His earlier work on real-time surgical margin assessment during laparoscopic and robot-assisted resections of colorectal liver metastases (2020, 71 citations) addresses the persistent challenge of margin-positive resections, which occur in nearly one-third of cases. By using ICG fluorescence to visualize tumor boundaries intraoperatively, Meijer's research provides surgeons with immediate feedback to achieve R0 resections. His contributions bridge the gap between imaging technology and surgical decision-making, offering practical solutions that enhance precision and safety in complex oncologic procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2